Alzheimer's biomarker and neuroimaging initiative (ADNI4)
Alzheimer's Disease Neuroimaging Initiative (ADNI4)
This project collects brain scans, blood and other samples from people with and without memory problems to improve tests that detect and track Alzheimer’s and to include more diverse participants in research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northern California Institute/res/edu NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11386830 on NIH RePORTER |
What this research studies
If you join, you may have brain imaging, blood draws, cognitive testing, and possibly cerebrospinal fluid collection at scheduled visits over time, with your data and samples stored in shared repositories. The team will follow hundreds of prior ADNI participants and recruit additional volunteers, with a strong focus on including people from underrepresented communities. Researchers will use the clinical, imaging, genetic, and fluid data to refine biomarkers (including new blood tests) that can identify Alzheimer’s changes earlier and make clinical trials more reliable. The project shares data widely so discoveries can speed development of future treatments.
Who could benefit from this research
Good fit: Ideal candidates include people with memory concerns, early cognitive symptoms, diagnosed mild cognitive impairment or Alzheimer’s, and also cognitively normal volunteers including those from underrepresented racial and ethnic groups.
Not a fit: People seeking an immediate therapeutic benefit or those unwilling/unable to attend repeated visits or undergo scans, blood draws, or lumbar puncture may not personally benefit from participation.
Why it matters
Potential benefit: If successful, this work could lead to better blood and imaging tests that detect Alzheimer’s earlier and make clinical trials faster and more accurate, benefiting future patients.
How similar studies have performed: Earlier ADNI phases and similar large biomarker consortia have produced thousands of publications and directly informed clinical trial design, showing a strong track record for this approach.
Where this research is happening
San Francisco, United States
- Northern California Institute/res/edu — San Francisco, United States (Active)
Researchers
- Principal investigator: Weiner, Michael W — Northern California Institute/res/edu
- Study coordinator: Weiner, Michael W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.